ArticleThe Permanente journal2021

Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse.

Rohan M Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.